Lv5
990 积分 2022-09-07 加入
Phase I and Pharmacokinetic Study of DE-310 in Patients with Advanced Solid Tumors
12天前
已完结
Development of Cagrilintide, a Long-Acting Amylin Analogue
26天前
已完结
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
26天前
已完结
First-line chemotherapy for mCRC—a review and evidence-based algorithm
28天前
已完结
New options for late-line treatment of metastatic colorectal cancer
28天前
已完结
CFT1946 Is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader That Overcomes BRAF Inhibitor Resistance
1个月前
已完结
RAF inhibitors that evade paradoxical MAPK pathway activation
1个月前
已完结
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
5个月前
已完结
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
5个月前
已完结
ZBTB11 Depletion Targets Metabolic Vulnerabilities in K-Ras Inhibitor Resistant PDAC
7个月前
已完结
皖公网安备34019202002308
